You are here

Axcella Health

Spotlight – Nash in 2023 and beyond

EP Vantage

Thu, 08/3/23 - 10:03 am

Boehringer Ingelheim

Akero Therapeutics

Ionis Pharmaceuticals

Gilead Sciences

Ascletis Pharma

'We beg you': Biotechs plead for help and funds to find long COVID treatments

Fierce Biotech

Wed, 02/22/23 - 06:59 pm

Flagship Pioneering

JPM23: After rock climbing in biotech, Novartis' CMO is back to support hopeful hike to US summit

Fierce Biotech

Thu, 01/12/23 - 10:36 am

Dicerna Pharmaceuticals

Axcella previews long Covid registrational trial plans in UK and US

Clinical Trials Arena

Wed, 08/3/22 - 10:45 am

clinical trials

Axcella's CEO knows people are tired of the pandemic. But long COVID patients need help, too

Fierce Biotech

Tue, 06/21/22 - 11:04 am

Former Novartis exec wants to repurpose generic drugs to fight Covid-19

Stat

Tue, 04/7/20 - 10:15 am

drug repurposing

Two Days, Five Biotech IPOs, and $359M Raised for Clinical Trials

Xconomy

Thu, 05/9/19 - 11:06 am

clinical trials

Milestone Pharmaceuticals

Trevi Therapeutics

Axcella Health Files for $86 Million IPO

CP Wire

Fri, 04/12/19 - 09:57 am

hepatic encephalopathy

Axcella Health Files for $86 Million IPO

Fri, 04/12/19 - 09:46 am

hepatic encephalopathy

Novartis Pharma Ex-CEO takes three roles in two days

Pharmafile

Sat, 01/6/18 - 12:36 pm